Moyamoya disease (MMD) is a rare, chronic vaso-occlusive disease affecting the arteries of the Circle of Willis, leading to the development of characteristic collateral vessels. In this paper, we present a case of a 35-year-old Hispanic male who presented to the emergency department with new onset headaches. On examination, Glasgow Coma Scale score was 3T. The patient was investigated with head CT scan and cerebral angiogram, diagnosed as MMD, and treated with emergent ventriculostomy. Ultimately, the patient underwent extracranial-intracranial (EC-IC) bypass surgery for treatment of Moyamoya.
Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized by progressive stenosis of the terminal portions of the intracranial internal carotid arteries due to hypertrophy of smooth muscle in the vessel walls [1-4]. Reduced blood flow to the brain leads to the growth of collateral vasculature such as branches from small leptomeningeal vessels. Imaging of the collateral vasculature was characterized in Japan as a “puff of smoke,” or moyamoya in Japanese. Incidence of MMD is the highest in Japan, where there are three cases per 100,000, and in females (2:1 ratio) . MMD is now seen throughout the world with a bimodal age of onset, with children presenting around age 5 and adults presenting around age 40 . The presentation in a child is typically a stroke or a transient ischemic attack, while in adults it is typically a hemorrhage. Less commonly, MMD may present with a headache or a seizure. MMD affects bilateral internal carotid arteries, whereas a unilateral presentation of the same underlying pathology is known as Moyamoya syndrome and is associated with conditions like Down syndrome, neurofibromatosis type 1, and sickle cell disease.
A 35-year-old Hispanic male presented to the emergency department for sudden onset worsening headaches over the past four days. Headaches were diffusely felt, not localized to a specific head region, and not relieved by over the counter pain medication. There was no associated trauma, fever, night sweats, loss of consciousness, photophobia, neck stiffness, or visual disturbances. His past medical history was significant for migraine headaches, type 2 diabetes mellitus, and benign essential hypertension. Physical exam revealed Glasgow Coma Scale score of 3T on 15L of oxygen, pupils 2-2.5 mm bilaterally, inability to arouse by voice or painful stimulation, and paralysis of upper and lower extremities bilaterally. Vitals include (heart rate = 89/min, blood pressure = 159/78 mmHg, temperature = 37°C, respiratory rate = 22/min, and oxygen saturation = 99% on 15L of oxygen). Labs were significant for respiratory alkalosis (blood pH 7.54, pCO2 27.5 mmHg), normal oxygenation (159.3 mmHg), and negative urinary toxicology screen.
A head CT scan revealed a 1.5 cm hematoma in the left thalamus with expansion into the lateral ventricle (Figure 1A). Cerebral angiogram demonstrated complete stenosis of the left internal carotid artery (ICA) and partial stenosis of the right ICA (Figures 1B-1C). Diagnostic studies coupled with clinical presentation were compatible with a diagnosis of MMD. Patient treatment was initialized with emergent bedside right ventriculostomy (with opening pressure of 11 cmH2O) for intracranial pressure monitoring and for diversion of cerebrospinal fluid and hematoma. This patient ultimately underwent surgical revascularization. The procedure included a left superficial temporal artery-left middle cerebral artery bypass without any complications.
Diagnosing MMD may be challenging but should be guided by its typical presentation, underlying pathology, and appropriate angiography studies. MMD is a cerebrovascular disorder characterized by progressive stenosis of the internal carotid arteries at their terminal portions [1-2]. As the arteries gradually occlude, a compensatory collateral network of leptomeningeal vessels in a “puff of smoke” formation develops to bypass the blockage. Patients who have these characteristic Moyamoya vascular findings, along with an underlying associated condition or a strongly associated risk factor such as radiotherapy to the head and neck (often for optic gliomas, or pituitary tumors) are classified as having Moyamoya syndrome. Patients without these known associated risk factors are said to have MMD, which is more common and is a bilateral disease. Therefore, a unilateral presentation is considered Moyamoya syndrome, and 40% of these patients will develop contralateral disease as well.
The incidence of MMD is the highest in Japan, but has now been reported in ethnicities across the world, such as the Hispanic male we present here. Interestingly, the disease is twice as common in females compared to males. MMD has a bimodal age of presentation. Children around 5 years of age present with symptoms of brain ischemia, often triggered by hyperventilation (e.g. transient ischemic attacks, ischemic strokes, neurological deficits, and alterations in consciousness). Adults present in their mid-40s with recurrent headache and intracranial hemorrhage, often in the subcortical brain structures such as the basal ganglia. The hemorrhage is likely due to rupture of fragile collateral vessels or the development of cerebral aneurysms from shear stress; headaches may be due to dilated leptomeningeal collateral vessels stimulating nociceptors in the dura.
Surgical revascularization is the primary treatment of MMD. Previous studies have estimated that without treatment, around two-thirds of Moyamoya patients have progression of symptoms over five years, with poor outcome . However, after surgical treatment, symptomatic progression is reduced to only 2.6%, with almost all patients remaining stroke free at a time point of five years after surgery [5-8]. The present patient discussed above was treated successfully with a direct extracranial-intracranial (EC-IC) arterial bypass surgery. The surgical revascularization options can be split into direct, indirect, and combined approaches. The direct EC-IC bypass performed here is commonly used in adult patients. The indirect encephalo-duro-arterio-syangiosis (EDAS) procedure involves laying down a branch of the superficial temporal artery onto the brain surface, allowing for neovascularization to supply blood flow to the tissue indirectly rather than a direct anastomosis. The EDAS procedure is more commonly performed in children.
Our case brings forth the importance of considering MMD in the differential diagnosis for patients suffering from recurrent headaches in their third or fourth decade, as well as in children around age 5 who have refractory headaches or signs of ischemia. This case also highlights a rare presentation in a Hispanic male individual, despite the disease predominantly affecting females of Asian heritage. In general, when working up a patient for headache with neurological deficits, the differential diagnosis should include transient ischemic attack or ischemic stroke (e.g. atherosclerosis, thromboembolism, inflammation or vasculitis, sickle cell disease, MMD), intracranial hemorrhage (aneurysm, trauma, MMD), or mass lesion (e.g. tumor, arteriovenous malformation).
- Miyamoto S, Yoshimoto T, Hashimoto N, et al.: Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014, 45:1415-1421. 10.1161/STROKEAHA.113.004386
- Scott RM, Smith ER: Moyamoya disease and Moyamoya syndrome. N Engl J Med. 2009, 360:1226-1237. 10.1056/nejmra0804622
- Kuroda S, Houkin K: Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008, 7:1056-1066. 10.1016/S1474-4422(08)70240-0
- Huang S, Guo ZN, Shi M, Yang Y, Rao M: Etiology and pathogenesis of Moyamoya disease: an update on disease prevalence. Int J Stroke. 2017, 12:246-253. 10.1177/1747493017694393
- Fung LW, Thompson D, Ganesan V: Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005, 21:358-364. 10.1007/s00381-004-1118-9
- Gudepu RK, Mohtashim AQ, Ihtesham AQ, Lakshman R: Case report: a case report of Moyamoya disease in a 36 year old African American woman. F1000Research. 2014, 3:297. 10.12688/f1000research.5859.1
- Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg Pediatr. 2004, 100:142-149. 10.3171/ped.2004.100.2.0142
- Choi JU, Seok Kim D, Kim EY, Lee KC: Natural history of Moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg. 2002, 99:S11-S18. 10.1016/s0303-8467(97)00033-4
A Case Report of Moyamoya Disease Presenting as Headache in a 35-year-old Hispanic Man
Ethics Statement and Conflict of Interest Disclosures
Human subjects: Consent was obtained by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Cite this article as:
Azzam D B, Sharma A N, Tiourin E, et al. (April 10, 2019) A Case Report of Moyamoya Disease Presenting as Headache in a 35-year-old Hispanic Man. Cureus 11(4): e4426. doi:10.7759/cureus.4426
Received by Cureus: March 18, 2019
Peer review began: April 02, 2019
Peer review concluded: April 02, 2019
Published: April 10, 2019
© Copyright 2019
Azzam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.